Ep. 109 - What's Next for Novartis? Plus: AACR, Merck KGaA
BioCentury This Week
00:00
Introduction
What's next for nevardis as it reorganizes? How germany's murk is shaping its pipe line following a few late stage clinical disappointments. What to look out for at the 20 second bioequity europe conference which finally kicks off this week. And we look ahead to this week's the bio century show, which will feature simone speaking with jamie reuben of e c r x.
Transcript
Play full episode
